Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus
01 October 2025
01 October 2025
Total investments received (USD): 112.83M
Round value (USD): 93.84M
Company: Trogenix
Related deals
Chemify raised $50 million Series B round led by Insight Partners and Wing.
Investments
10 October 2025
Comind to raise $60M series B led by Plural, joined by Angelini, LocalGlobe, Octopus Ventures, Crane Venture Partners, BACKED VC and Entrepreneurs First.
Investments
09 October 2025
Elevara Medicines raised $70m in Series A funding led by Forbion and Sofinnova Partners, joined by insiders Monograph Capital and Weatherden.
Investments
02 October 2025
NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds
Investments
01 September 2025
Charm Therapeutics raised $80M Series B round co-led by New Enterprise Associates and SR One, w/ OrbiMed, F-Prime Capital, Khosla Ventures, and NVIDIA
Investments
02 August 2025
Belgium
Austria
Denmark
Estonia
Finland
Iceland
Lithuania
Norway
Sweden
Ireland
Portugal